A szorongásos betegségek farmakoterápiája.

Translated title of the contribution: Pharmacotherapy of anxiety disorders

Research output: Contribution to journalArticle

Abstract

The pharmacotherapy of anxiety disorders has revolutionary changed in the last few years. This ICD-10 based review of the literature provides help for general practitioners and other specialists in the short and long term treatment of anxiety as well as in the discontinuation of pharmacologic treatment. The author describes the use of high potency benzodiazepines, selective serotonin reuptake inhibitors and 5 HT1A partial agonists and summarizes the disadvantages of some older drugs still in use for the treatment of anxiety disorders.

Original languageHungarian
Pages (from-to)2435-2439
Number of pages5
JournalOrvosi Hetilap
Volume136
Issue number45
Publication statusPublished - Nov 5 1995

Fingerprint

Anxiety Disorders
Drug Therapy
Serotonin 5-HT1 Receptor Agonists
Serotonin Uptake Inhibitors
International Classification of Diseases
Benzodiazepines
General Practitioners
Therapeutics
Anxiety
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A szorongásos betegségek farmakoterápiája. / Bitter, I.

In: Orvosi Hetilap, Vol. 136, No. 45, 05.11.1995, p. 2435-2439.

Research output: Contribution to journalArticle

Bitter, I. / A szorongásos betegségek farmakoterápiája. In: Orvosi Hetilap. 1995 ; Vol. 136, No. 45. pp. 2435-2439.
@article{6dd8827432ee4baeafc939eaf0d72cd0,
title = "A szorong{\'a}sos betegs{\'e}gek farmakoter{\'a}pi{\'a}ja.",
abstract = "The pharmacotherapy of anxiety disorders has revolutionary changed in the last few years. This ICD-10 based review of the literature provides help for general practitioners and other specialists in the short and long term treatment of anxiety as well as in the discontinuation of pharmacologic treatment. The author describes the use of high potency benzodiazepines, selective serotonin reuptake inhibitors and 5 HT1A partial agonists and summarizes the disadvantages of some older drugs still in use for the treatment of anxiety disorders.",
author = "I. Bitter",
year = "1995",
month = "11",
day = "5",
language = "Hungarian",
volume = "136",
pages = "2435--2439",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "45",

}

TY - JOUR

T1 - A szorongásos betegségek farmakoterápiája.

AU - Bitter, I.

PY - 1995/11/5

Y1 - 1995/11/5

N2 - The pharmacotherapy of anxiety disorders has revolutionary changed in the last few years. This ICD-10 based review of the literature provides help for general practitioners and other specialists in the short and long term treatment of anxiety as well as in the discontinuation of pharmacologic treatment. The author describes the use of high potency benzodiazepines, selective serotonin reuptake inhibitors and 5 HT1A partial agonists and summarizes the disadvantages of some older drugs still in use for the treatment of anxiety disorders.

AB - The pharmacotherapy of anxiety disorders has revolutionary changed in the last few years. This ICD-10 based review of the literature provides help for general practitioners and other specialists in the short and long term treatment of anxiety as well as in the discontinuation of pharmacologic treatment. The author describes the use of high potency benzodiazepines, selective serotonin reuptake inhibitors and 5 HT1A partial agonists and summarizes the disadvantages of some older drugs still in use for the treatment of anxiety disorders.

UR - http://www.scopus.com/inward/record.url?scp=0029637112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029637112&partnerID=8YFLogxK

M3 - Article

VL - 136

SP - 2435

EP - 2439

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 45

ER -